Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USAK
2826
DELISTED
USA Truck Inc
USAK
| $600K | ﹤0.01% |
40,093
-47,619
| -54% | -$878K |
|
2827
CALL
Evolent Health
EVH
$553M
| $599K | ﹤0.01% |
+30,000
| New | +$694K |
|
2828
PUT
A.O. Smith
AOS
$8.45B
| $598K | ﹤0.01% |
+14,000
| New | +$644K |
|
2829
Inspired Entertainment
INSE
$158M
| $598K | ﹤0.01% |
124,535
-47,886
| -28% | -$298K |
|
2830
Global Net Lease
GNL
$2.14B
| $597K | ﹤0.01% |
+33,900
| New | +$675K |
|
2831
iShares MSCI Turkey ETF
TUR
$222M
| $597K | ﹤0.01% |
+24,290
| New | +$595K |
|
|
KG
2832
Kestrel Group
KG
$58.8M
| $594K | ﹤0.01% |
17,987
-20,609
| -53% | -$1.11M |
|
2833
Tilray
TLRY
$671M
| $593K | ﹤0.01% |
840
+604
| +256% | +$662K |
|
2834
Wave Life Sciences
WVE
$1.03B
| $593K | ﹤0.01% |
14,117
-72,232
| -84% | -$3.21M |
|
|
AFH
2835
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
| $593K | ﹤0.01% |
73,324
-39,857
| -35% | -$381K |
|
|
CCRN
2836
DELISTED
Cross Country Healthcare
CCRN
| $592K | ﹤0.01% |
80,810
+59,120
| +273% | +$496K |
|
2837
Universal Insurance Holdings
UVE
$1.2B
| $590K | ﹤0.01% |
15,570
+11,359
| +270% | +$494K |
|
2838
Kinsale Capital Group
KNSL
$8.84B
| $588K | ﹤0.01% |
+10,582
| New | +$625K |
|
2839
Vitamin Cottage Natural Grocers
NGVC
$651M
| $588K | ﹤0.01% |
38,353
-99,112
| -72% | -$1.75M |
|
|
CLSD
2840
DELISTED
Clearside Biomedical
CLSD
| $586K | ﹤0.01% |
36,525
-23,437
| -39% | -$1.1M |
|
2841
MidCap Financial Investment
MFIC
$797M
| $585K | ﹤0.01% |
+47,172
| New | +$718K |
|
2842
Republic Bancorp
RBCAA
$1.85B
| $584K | ﹤0.01% |
15,080
+678
| +5% | +$29.1K |
|
|
TAHO
2843
DELISTED
Tahoe Resources Inc
TAHO
| $584K | ﹤0.01% |
+160,057
| New | +$492K |
|
2844
Energizer
ENR
$1.5B
| $583K | ﹤0.01% |
12,913
-40,488
| -76% | -$2.15M |
|
|
LMNX
2845
DELISTED
Luminex Corp
LMNX
| $583K | ﹤0.01% |
25,217
+3,408
| +16% | +$91.8K |
|
2846
Stagwell
STGW
$2.13B
| $582K | ﹤0.01% |
223,133
+158,037
| +243% | +$450K |
|
2847
Tejon Ranch
TRC
$437M
| $582K | ﹤0.01% |
+35,077
| New | +$652K |
|
2848
Banc of California
BANC
$2.95B
| $579K | ﹤0.01% |
43,525
+1,878
| +5% | +$30.5K |
|
2849
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$54.1B
| $579K | ﹤0.01% |
+17,813
| New | +$623K |
|
2850
OptimizeRx
OPRX
$148M
| $577K | ﹤0.01% |
52,590
-32,373
| -38% | -$479K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.